Neovasc Investor Relations Material

Latest events

Q3 2022

Neovasc

Q4 2022

31 Mar, 2023

Corporate Strategy Update

11 Nov, 2022
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Neovasc Inc

Access all reports
Neovasc Inc. is a medical device company that focuses on the development of products for the treatment of cardiovascular diseases. The company's primary offerings include devices designed to address refractory angina, a chronic condition characterized by chest pain, and to support heart valve repair procedures. The company is headquartered in Richmond, Canada, and its shares are listed on the NASDAQ.